Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SNP-Based Chromosomal Microarray Analysis in the Era of Optical Genome Mapping: An Enriched Case-Series Evaluating Copy-Neutral Events.

Cancers·2026
Same author

Concomitant Clonal <i>CBFB</i>::<i>MYH11</i> and <i>PDGFRB</i> Fusions in a Case of <i>De Novo</i> Acute Myeloid Leukemia.

Hematology reports·2026
Same author

Phase Determination and Demonstration of Parental Mosaicism of Intragenic <i>PRKN</i> Deletions Initially Identified by Chromosomal Microarray Analysis.

Genes·2025
Same author

Integration of Newer Genomic Technologies into Clinical Cytogenetics Laboratories.

Genes·2025
Same author

Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group.

Blood cancer journal·2025
Same author

Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry.

Human pathology·2025

Related Experiment Video

Updated: Jul 11, 2026

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Comprehensive validation of array comparative genomic hybridization platforms: how much is enough?

Erik C Thorland1, Patrick R Gonzales, Troy J Gliem

  • 1Cytogenetics Laboratory, Division of Laboratory Genetics, Department of Laboratory Genetics and Pathology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota, USA. thorland.erik@mayo.edu

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|September 18, 2007
PubMed
Summary

Array comparative genomic hybridization (CGH) platforms show high accuracy in detecting subtelomere abnormalities but require thorough validation. Two false negatives highlight the need for careful implementation in clinical cytogenetic testing.

More Related Videos

Technical Demonstration of Whole Genome Array Comparative Genomic Hybridization
16:37

Technical Demonstration of Whole Genome Array Comparative Genomic Hybridization

Published on: August 5, 2008

An Array-based Comparative Genomic Hybridization Platform for Efficient Detection of Copy Number Variations in Fast Neutron-induced Medicago truncatula Mutants
09:32

An Array-based Comparative Genomic Hybridization Platform for Efficient Detection of Copy Number Variations in Fast Neutron-induced Medicago truncatula Mutants

Published on: November 8, 2017

Related Experiment Videos

Last Updated: Jul 11, 2026

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Technical Demonstration of Whole Genome Array Comparative Genomic Hybridization
16:37

Technical Demonstration of Whole Genome Array Comparative Genomic Hybridization

Published on: August 5, 2008

An Array-based Comparative Genomic Hybridization Platform for Efficient Detection of Copy Number Variations in Fast Neutron-induced Medicago truncatula Mutants
09:32

An Array-based Comparative Genomic Hybridization Platform for Efficient Detection of Copy Number Variations in Fast Neutron-induced Medicago truncatula Mutants

Published on: November 8, 2017

Area of Science:

  • Genetics
  • Genomics
  • Cytogenetics

Background:

  • Array comparative genomic hybridization (CGH) is increasingly used in cytogenetic testing.
  • Validation studies for commercial array CGH platforms are scarce.
  • Subtelomere abnormalities require precise detection for accurate diagnosis.

Purpose of the Study:

  • To validate a commercial array CGH platform for detecting subtelomere abnormalities.
  • To assess the performance of the Spectral Genomics Constitutional Chip 3.0.
  • To identify challenges in array CGH validation for clinical use.

Main Methods:

  • A blinded study was conducted on 67 patients with known subtelomere abnormalities.
  • The Spectral Genomics Constitutional Chip 3.0 was used for testing.
  • Results were compared against previous cytogenetic studies.

Main Results:

  • The array CGH platform demonstrated 97% concordance (72 of 74 abnormalities).
  • Two false-negative results were observed.
  • Issues with mismapped and suboptimal clones potentially affect detection of specific abnormalities (e.g., 6q, 20q).

Conclusions:

  • Comprehensive validation of array CGH platforms is crucial before clinical implementation.
  • Potential limitations in clone performance necessitate careful consideration.
  • Adherence to guidelines, such as those from the American College of Medical Genetics, is recommended for microarray analysis.